Symbol
LXEO on Nasdaq
Investment type
Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership
3.07M shares
Security Ownership
5.7%

Frazier Life Sciences Public Fund, L.P. ownership in Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share (LXEO)

2025-08-14 - Frazier Life Sciences Public Fund, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.07M shares of Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share (LXEO). This represents 5.7% percent ownership of the company.